최원석

  #감염질환#발열#예방접종#성인예방접종

학력

1996 .03 ~ 2002 .02 : 고려대학교 의과대학 졸업 학사
2004 .09 ~ 2006 .08 : 고려대학교 대학원 석사
2006 .09 ~ 2009 .02 : 고려대학교 대학원 박사

경력

2002 .03 ~ 2003 .02 : 고려대학교 의료원 인턴
2003 .03 ~ 2007 .02 : 고려대학교 의료원 내과 전공의
2007 .03 ~ 2008 .02 : 질병관리본부 예방접종관리팀 (책임)연구원
2008 .03 ~ 2009 .02 : 고려대학교 구로병원 감염내과 전임의
2009 .03 ~ 2011 .02 : 고려대학교 안산병원 감염내과 임상강사
2009 .09 ~ 2011 .02 : 고려대학교 의과대학 감염내과 겸임교수
2011 .03 ~ 2016 .02 : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 조교수
2016 .03 ~ : 고려대학교 의과대학 내과학교실(고려대학교 안산병원) 감염내과 부교수
2012 ~ 2014 : 고려대학교 안산병원 감염내과 과장
2012 ~ 2014 : 고려대학교 안산병원 감염관리실장
2014 ~ 2017 : 고려대학교 안산병원 진료협력센터 부센터장
2014 ~ : 고려대학교 안산병원 임상시험심사위원회 위원(전문간사)
2007 ~ 2008 : 질병관리본부 질병예방센터 예방접종관리과 (책임)연구원
2009 ~ 2010 : 질병관리본부 예방접종관리과 신종인플루엔자 백신 실무자문단
2015 ~ 2017 : 대한화학요법학회(現 대한항균요법학회) 기획이사
2015 .06 ~ 2015 .07 : 경기도 메르스중점치료센터 부센터장
2017 .04 ~ 2017 .08 : 질병관리본부 예방접종피해보상 전문위원회 위원
2017 ~ 2018 : Visiting scholar in University of Pittsburgh
2012 ~ : 대한감염학회 성인예방접종위원회 위원(간사)
2013 ~ : 질병관리본부 예방접종전문위원회 분과위원
2016 ~ : 경기도 감염병관리지원단 자문위원
2016 ~ : 식품의약품안전처 중앙약사심의위원회 전문가
2017 ~ : 질병관리본부 즉각대응팀 민간전문가
2019 ~ : 대한항균요법학회 교육이사

논문

[SCI] (Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults)

[SCI] (Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study)

[SCI] (The National Influenza Surveillance System of Korea.)

[SCI] (Safety and Effectiveness Analysis of Kivexa??(lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients)

[SCI] (Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax?? in healthy adults aged 50 years and older)

[국내논문] (Clinical and economic analysis of the 2009 H1N1 influenza pandemic among pregnant Korean women)

[SCI] (Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis.)

[SCI] (Current status of indwelling urinary catheter utilization and catheter-associated urinary tract infection throughout hospital wards in Korea: A multicenter prospective observational study.)

[SCI] (Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers.)

[SCI] (Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis)

[SCI] (Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18?60 years of age in the Republic of Korea.)

[SCI] (Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older)

[SCI] (Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea)

[SCI] (Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data)

[SCI] (1. Significant circulation of influenza b viruses mismatching the recommended vaccine-lineage in South Korea, 2007?2014)

[SCI] (Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group.)

[SCI] (Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea)

[SCI] (Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: A nationwide multicenter study)

[SCI] (Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching)

[SCI] (Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation)

[SCI] (Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ≥60-year-old adults)

[SCI] (Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly)

[SCI] (Disease burden of 2013-2014 seasonal influenza in adults in Korea)

[SCI] (Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects)

[SCI] (Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults)

[SCI] (Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea)

[SCI] (Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season)

[SCI] (Suboptimal effectiveness of 2011-2012 influenaza vaccine in adult Korean populations)

[SCI] (Chronic Cavitary Pulmonary Histoplasmosis in a Non-HIV and Immunocompromised Patient without Overseas Travel History)

[SCI] (Immunity and the burden of herpes zoster)

[SCI] (Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population)

[SCI] (Clinical practice guideline for antiviral treatment and chemoprophylaxis of seasonal influenza)

[SCI] (Skin and soft tissue infections: Experience over a five-year period and clinical usefulness of ultrasonography-guided gun biopsy-based culture)

[SCI] (Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine)

[SCI] (The Clinical Usefulness of the SD Bioline Influenza Antigen Test (R) for Detecting the 2009 Influenza A (H1N1) Virus)

[SCI] (Outbreak of Measles in the Republic of Korea, 2007: Importance of Nosocomial Transmission)

[SCI] (Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study)

[SCI] (Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea)

[국외논문] (Timeliness of MMR vaccination and barriers to vaccination in preschool children)

[SCI] (Seroprevalence of Varicella-zoster Virus in Korea)

[SCI] (Liver Abscess and Empyema due to Lactococcus lactis cremoris)

[국내논문] 국내 침습성 폐렴알균 감염증의 임상양상

[SCI] (Disease Burden of Herpes zoster in Korea)

[국내논문] 2009년 발생한 신종인플루엔자 대유행에 대한 정책적 대응 평가

[국내논문] 신종인플루엔자 대유행에 대한 백신 대응 전략

[SCI] (Are gastric acid suppressants a risk factor for enteric peritonitis)

[국내논문] 우리나라의 백신 정책

[SCI] (Appropriateness of prophylactic antibiotic usage for major surgery in Korea)

[국내논문] 지속성 균혈증 및 진균혈증 - 위험인자 및 임상적 중요성

[국내논문] Vancomycin 내성 장구균에 의한 세균뇨의 역학과 임상적 중요성

[SCI] (CAPD peritonitis due to Brevundimonas vesicularis)

저서

알기 쉬운 항생제 처방
성인예방접종 3판
노년내과학
노인의학
항생제의 길잡이
인플루엔자
노인병학 제3판
성인예방접종 2판

보도자료

美, 코로나19 치료제 '렘데시비르' 공식 인정…의미는
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=055&aid=0000811749

코로나19 '항체 형성' 확인…지속기간·방어력 등은 수수께끼
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=001&aid=0011565820

오늘부터 미국발 입국자도 모두 검사… 무증상 전파 막는다
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=005&aid=0001310615

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.